Skip to content
SCIENCE OF CERTAINTY

Comprehensive Histology Services for Precision Research

Our experienced scientists and histopathologists leverage AI-powered quantification tools to deliver unbiased and precise data analysis for fast and reproducible histological studies. We offer whole-organ image analysis using a range of histological techniques, RNAscope™ multiplexing tailored to several disease models, immunofluorescence (IF), immunohistochemistry (IHC), and histological stains.

A High-Quality Histology Analysis​ to Accelerate the Progress ​of Your Preclinical Pipeline​

High-throughput slide analysis combining AI and conventional tools
  • High-throughput slide imaging
  • Multiplex immunofluorescence and RNAscope™ in CNS studies 
  • AI-based histopathological scoring using Gubra’s Histopathological Objective Scoring Technique (GHOST)
  • Quantitative and qualitative histological analysis 
  • Applicable to all organ types in mice, rats, and beyond 

Histology service workflow overview

AI-Powered Histopathology Scoring​

Gubra Histopathological Objective Scoring Technology, GHOST, provides high reproducibility with a rapid turnaround time for your study.

AI-Powered Histopathology Scoring
Objective and consistent drug efficacy testing in preclinical models​ ​

Standardized scoring and objective assessment for: ​

  • MASH: NAFLD activity score, fibrosis stage – Kleiner score and Ishak score
  • IPF: Ashcroft score of pulmonary fibrosis
  • CKD: Glomerulosclerosis​

AI-powered precision of histopathological scoring provides: 

  • Reduced variability by minimizing both inter- and intra-observer inconsistencies​
  • Reproducible scoring across studies
  • Enhanced reproducibility increases confidence in data, enabling more accurate evaluations.

Expression analysis of RNA, protein, or both molecules

  • Fresh frozen or FFPE serial sectioning​
  • Multiplexed RNAscope for analysis of RNA expression
  • Multiplexed protein detection via immunohistochemistry or immunofluorescence 
  • Codetection of RNA and protein in the same section
  • AI-assisted cell detection in areas of interest directed by expression profile  

Obesity

White Adipose Tissue (WAT)

Follow adipose tissue changes with your therapy in our DIO mouse and rat models by following changes in white adipose tissue (WAT) with histological stains and IHC.

  • Quanitfy of size and number of adipocytes in WAT with H&E stained FFPE slides.
  • Detect WAT inflammation by immunohistochemical staining for F4/80, Gal3, CD11b, CD45, CD3, or CD20 markers.
Skeletal Muscle 

Quantify sarcopenia development, myosteatosis, and muscle health in our DIO rodent models.

  • Utilize cross sectional analysis of laminin with IHC on FFPE sections to assess for sarcopenia.
  • Identify lipid accumulation utilizing ORO or H&E to determine the lipid accumulation and intramuscular adipose tissue seen in myosteatosis.
  • Assess muscle health (vascularization, glucose transport, or glycogen storage) with staining for CD31 and GLUT4 or utilize PAS staining.
Liver Tissue

Detect liver steatosis by H&E-stained macrovesicular lipid droplets and Oil Red O-stained microvesicular lipid droplets.

MASH (Metabolic dysfunction-Associated Steatohepatitis)

AI-assisted scoring of NAFLD Activity Score

Determine the disease severity in our rodent models of MASH using GHOST to obtain an unbiased, clinically derived NAFLD activity score – a composite score of steatosis, lobular inflammation, and ballooning degeneration.

H&E of liver section

Detection of tissue, portal triads and central veins

Quantification of
*1 hepatocytes with and without lipids
*2 Inflammatory cell and foci
Balloned hepatocytes

Final NAFLD score

AI-Assisted Scoring of Fibrosis Stage

Identify the recovery of clinically derived fibrosis stage – both CRN and Ishak scoring – with GHOST in our MASH rodent models.

Fibrous liver sample

Tiles scored from 0-4 (CRN score)

CKD (Chronic Kidney Disease)

Glomerulosclerosis Score

Our AI-assisted GHOST glomerulosclerosis scoring method offers unbiased, accurate, and automated glomerulosclerosis assessment in both mouse and rat models of CKD.

GS0: Normal
GS1: Up to 25%
GS2: Up to 50%
GS3: Up to 75%
GS4: Global

Raw image

Grid analysis

Glomeruli detection

Glomerulosclerosis Score

IPF (Idiopathic Pulmonary Fibrosis)

Histopathological-Modified Ashcroft Score

Modified Ashcroft scoring applied to the entire left lung in control (CTRL) and bleomycin-induced IPF (BLEO-IPF) mice. Ashcroft score is depicted using a heat map with a score of 0 being white and a score of 8 being red in individual lung image tiles. 

  • Our AI-powered platform, GHOST, evaluates idiopathic pulmonary fibrosis (IPF) with modified Ashcroft scoring. Leveraging deep learning algorithms, GHOST analyses lung tissue images, providing precise modified Ashcroft scores and minimizing inter-observer variability. This unique method accelerates pipelines and ensures standardized assessments across IPF studies. 

IHC (Immunohistochemistry)

AI-assisted and conventional immunohistochemistry (IHC) image analysis methods enable efficient marker detection in all tissue types and many species.

Kidney fibrosis α-SMA 
Quantification of α-SMA (brown, green) IHC staining, evaluating myofibroblast activation in the kidney.

Lung fibrosis Col1a1
IHC staining of Col1a1 in the lung. Quantification is performed by excluding large veins (yellow) from the analysis of positive signals (green).

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm, Denmark
+45 3152 ­2650

Back To Top